JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Achor, L. B.
Right arrow Articles by Geiling, E. M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Achor, L. B.
Right arrow Articles by Geiling, E. M. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 117, Issue 1, 16-19, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics


MORPHINE ANTAGONISTS. I. THE DISTRIBUTION AND EXCRETION OF MORPHINE-C14 IN THE PRESENCE OF N-ALLYL NORMORPHINE AND 5-AMINOACRIDINE

Leonard B. Achor 1 and E. M. K. Geiling 1

1 Department of Pharmacology, University of Chicago, Chicago, Illinois

The administration of N-allyl normorphine 25 mgm./kgm. or 5-aminoacridine 2.5 mgm./kgm. to mice previously given 10 mgm./kgm. morphine-C14 (54,400 cpm./20 gm. body weight) produces marked changes in distribution and excretion of radioactivity. All tissues examined are affected to a greater or lesser degree, but special reference is made to liver, kidney, small intestine and urine. NANM-treated animals accumulate radioactivity in bladder urine at approximately the same rate as controls, but void within two hours following administration of morphine and antagonist. The percentage injected dose excreted by control mice is approximately equal at 6 hours to that excreted by the NANM-treated group at the end of two hours. 5-Aminoacridine also facilitates the excretion of radioactivity following doses of morphine-C14, and appears to be more active in this respect than NANM. Furthermore, the distribution pattern of 5AA presents certain differences from those observed in the presence of NANM, indicating a possibly different mode of action. The possibility that both these antagonists alter the free:bound morphine ratio in urine has been suggested by the distribution data and is being investigated at this time.

Submitted on November 23, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.